NCT04173208View on ClinicalTrials.gov

Main Trial of the Cesarean Section and Intestinal Flora of the Newborn Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 10, 2019

Primary Completion Date

January 16, 2024

Study Completion Date

January 31, 2025

Conditions
Fecal Microbiota TransplantationCesarean Section, Affecting Fetus or NewbornIntestinal Microbiome
Interventions
OTHER

Fecal microbial transplant

Fecal microbial transplant

OTHER

Placebo

Placebo

Trial Locations (1)

00029

Children's Hospital, Helsinki University Hospital, Pediatric Research Center, Helsinki

All Listed Sponsors
collaborator

University of Helsinki

OTHER

lead

Helsinki University Central Hospital

OTHER

NCT04173208 - Main Trial of the Cesarean Section and Intestinal Flora of the Newborn Study | Biotech Hunter | Biotech Hunter